Silence Therapeutics plc
SLN
$13.55
-$0.14-1.02%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -59.95M | -75.04M | -88.61M | -64.54M | -79.13M |
| Total Depreciation and Amortization | 483.00K | 523.00K | 555.00K | 582.00K | 577.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.92M | 11.94M | 15.63M | 7.17M | 19.01M |
| Change in Net Operating Assets | 14.29M | -2.99M | 10.16M | -15.68M | -27.64M |
| Cash from Operations | -42.26M | -65.57M | -62.27M | -72.47M | -87.18M |
| Capital Expenditure | -3.00K | -51.00K | -55.00K | -117.00K | -178.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 72.89M | 6.44M | -47.94M | 71.59M | -17.78M |
| Cash from Investing | 72.89M | 6.39M | -47.99M | 71.47M | -17.96M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.00K | 1.00K | 15.00K | 15.00K | 7.99M |
| Repurchase of Common Stock | -- | -- | -- | -98.00K | -98.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.00K | 1.00K | 15.00K | -83.00K | 7.89M |
| Foreign Exchange rate Adjustments | -315.00K | -54.00K | 195.00K | 165.00K | 539.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30.32M | -59.23M | -110.05M | -912.00K | -96.71M |